Literature DB >> 2661656

The narcotic bowel syndrome.

M Rogers1, J J Cerda.   

Abstract

In this editorial, we review the narcotic bowel syndrome, its etiology, presentation, and treatment. We suggest this is an often overlooked diagnosis in many clinical settings.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2661656

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


  13 in total

1.  Chronic Functional Abdominal Pain (CFAP).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

Review 2.  Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures.

Authors:  J R Malagelada; E Distrutti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 3.  The narcotic bowel syndrome: a recent update.

Authors:  Douglas Drossman; Eva Szigethy
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

Review 4.  Opioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategies.

Authors:  Ankush Sharma; M Mazen Jamal
Journal:  Curr Gastroenterol Rep       Date:  2013-07

5.  The narcotic bowel syndrome: clinical features, pathophysiology, and management.

Authors:  David M S Grunkemeier; Joseph E Cassara; Christine B Dalton; Douglas A Drossman
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10       Impact factor: 11.382

6.  [Pharmacotherapy of cancer pain : 2. Use of opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-01       Impact factor: 1.107

7.  Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study.

Authors:  Rok Seon Choung; G Richard Locke; Alan R Zinsmeister; Cathy D Schleck; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-04-14       Impact factor: 10.864

8.  A case of narcotic bowel syndrome successfully treated with clonidine.

Authors:  V Wong; G Sobala; M Losowsky
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

9.  Biopsychosocial model of irritable bowel syndrome.

Authors:  Yukari Tanaka; Motoyori Kanazawa; Shin Fukudo; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

Review 10.  Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors.

Authors:  J K DiBaise; E M Quigley
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.487
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.